CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Top Cited Papers
- 1 July 2011
- journal article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 9 (1), 50-63
- https://doi.org/10.1016/j.stem.2011.06.005
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Stem Cells in Hepatocarcinogenesis: Evidence from Genomic DataSeminars in Liver Disease, 2010
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid TumorsCancer Cell, 2009
- Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatmentProceedings of the National Academy of Sciences of the United States of America, 2009
- Nanog Is the Gateway to the Pluripotent Ground StateCell, 2009
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell FeaturesGastroenterology, 2009
- The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signalingOncogene, 2009
- Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signalingProceedings of the National Academy of Sciences of the United States of America, 2008
- Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003